Richard Vincent | CFO |
Jim Breitmeyer | President and CEO |
Frank Hsu | Chief Medical Officer |
Hartaj Singh | Oppenheimer |
Carl Byrnes | Northland Securities |
Robert Burns | H.C. Wainwright |
Greetings, and welcome to the Oncternal Therapeutics Incorporated First Quarter Financial Results Conference Call.
At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mr.